M, B., A, M., J, B., A, P., M, S., S, G., . . . JM, L. (2022). Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study. Pancreas, 51(7), 756. https://doi.org/10.1097/MPA.0000000000002100
Chicago Style (17th ed.) CitationM, Boutin, et al. "Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study." Pancreas 51, no. 7 (2022): 756. https://doi.org/10.1097/MPA.0000000000002100.
MLA (9th ed.) CitationM, Boutin, et al. "Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study." Pancreas, vol. 51, no. 7, 2022, p. 756, https://doi.org/10.1097/MPA.0000000000002100.